Literature DB >> 11680584

Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver?

Y Tsushima1, M J Blomley, H Yokoyama, S Kusano, K Endo.   

Abstract

Our objective was to investigate if hepatic arterial (HAP) and portal venous perfusion (PVP) in apparently normal areas of liver, as measured by functional CT, are affected by the presence of extra- and intrahepatic malignancy Three patient groups were compared: A, controls with no malignancy (N = 10); B, extrahepatic malignancy without liver involvement (N = 12); and C, subjects with metastases elsewhere in the liver (N = 13). HAP, PVP, and a CT hepatic perfusion index (CT-HPI) calculated as HAP/(HAP + PVP) were calculated on a section free of metastatic disease, using a previously published method. Figures for PVP were (median and interquartile range) in group A were 1.06 (0.9-1.30), in B 1.03 (0.81-1.09), and in C 0.75 (0.54-1.02) ml/min/ml; for HAP group A values were 0.07 (0.052-0.078), in B 0.07 (0.053-0.147), and in C 0.12 (0.091-0.146) ml/min/ml and for CT-HPI Group A values were 4.9% (4.8-6.6%), in B 5.6% (3.8-13.6%), and in C 14.3% (10.4-15.4%). Significant differences in all indices were seen between groups A and C. A significant difference (P = 0.017) was seen between groups B and C in the CT-HPI values. In conclusion, patients with liver metastases show abnormal blood flow in apparently normal liver compared to controls. This difference was not seen in subjects with malignancy without liver metastases. Possible explanations would be either the unmasking of occult metastatic disease or vasoactive or mechanical effects due to liver malignancy.

Entities:  

Mesh:

Year:  2001        PMID: 11680584     DOI: 10.1023/a:1011990226667

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT.

Authors:  J F Platt; I R Francis; J H Ellis; K A Reige
Journal:  Radiology       Date:  1997-10       Impact factor: 11.105

2.  Hepatic Doppler perfusion index: measurement in nine healthy volunteers.

Authors:  R C Fowler; K M Harris; S E Swift; M Ward; D C Greenwood
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

3.  Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases.

Authors:  M J Blomley; T Albrecht; D O Cosgrove; V Jayaram; R J Eckersley; N Patel; S Taylor-Robinson; A Bauer; R Schlief
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

4.  Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?

Authors:  D H Sheafor; J S Killius; E K Paulson; D M DeLong; A M Foti; R C Nelson
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

5.  Doppler index perfusion in the detection of hepatic metastases secondary to gastric carcinoma.

Authors:  E Leen; J R Anderson; J Robertson; P O'Gorman; T G Cooke; C S McArdle
Journal:  Am J Surg       Date:  1997-02       Impact factor: 2.565

6.  Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer.

Authors:  K C Ballantyne; R M Charnley; A C Perkins; G Pye; D R Whalley; M L Wastie; J D Hardcastle
Journal:  Nucl Med Commun       Date:  1990-01       Impact factor: 1.690

7.  Comparison of the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver metastases. Evaluation with postoperative follow-up results.

Authors:  E Leen; W J Angerson; H Wotherspoon; B Moule; T G Cooke; C S McArdle
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

8.  Image-directed Doppler ultrasonography: a novel technique for the diagnosis of colorectal liver metastases.

Authors:  E Leen; J A Goldberg; J Robertson; W J Angerson; G R Sutherland; T G Cooke; C S McArdle
Journal:  J Clin Ultrasound       Date:  1993-05       Impact factor: 0.910

9.  Early detection of occult colorectal hepatic metastases using duplex colour Doppler sonography.

Authors:  E Leen; J A Goldberg; J Robertson; W J Angerson; G R Sutherland; T G Cooke; C S McArdle
Journal:  Br J Surg       Date:  1993-10       Impact factor: 6.939

10.  Splanchnic blood flow changes in the presence of hepatic tumour: evidence of a humoral mediator.

Authors:  R Carter; J H Anderson; T G Cooke; J N Baxter; W J Angerson
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more
  10 in total

1.  Quantification of hepatic arterial and portal perfusion with dynamic computed tomography: comparison of maximum-slope and dual-input one-compartment model methods.

Authors:  Masaya Miyazaki; Yoshito Tsushima; Akiko Miyazaki; Bishnuhari Paudyal; Makoto Amanuma; Keigo Endo
Journal:  Jpn J Radiol       Date:  2009-05-03       Impact factor: 2.374

2.  Dynamic contrast-enhanced CT imaging of hepatocellular carcinoma in cirrhosis: feasibility of a prolonged dual-phase imaging protocol with tracer kinetics modeling.

Authors:  Tong San Koh; Choon Hua Thng; Septian Hartono; Puor Sherng Lee; Su Pin Choo; Donald Y H Poon; Han Chong Toh; Sotirios Bisdas
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

Review 3.  Perfusion magnetic resonance imaging of the liver.

Authors:  Choon Hua Thng; Tong San Koh; David J Collins; Dow Mu Koh
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

4.  Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?

Authors:  Sheng-Xiang Rao; Doenja Mj Lambregts; Roald S Schnerr; Wenzel van Ommen; Thiemo Ja van Nijnatten; Milou H Martens; Luc A Heijnen; Walter H Backes; Cornelis Verhoef; Meng-Su Zeng; Geerard L Beets; Regina Gh Beets-Tan
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

5.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.

Authors:  Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
Journal:  Eur Radiol       Date:  2006-10-27       Impact factor: 5.315

Review 6.  Multiparametric MR Imaging in Abdominal Malignancies.

Authors:  Antonio Luna; Shivani Pahwa; Claudio Bonini; Lidia Alcalá-Mata; Katherine L Wright; Vikas Gulani
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

Review 7.  CT perfusion of the liver: principles and applications in oncology.

Authors:  Se Hyung Kim; Aya Kamaya; Jürgen K Willmann
Journal:  Radiology       Date:  2014-08       Impact factor: 11.105

8.  Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases.

Authors:  Martijn R Meijerink; Jan Hein T M van Waesberghe; Lineke van der Weide; Petrousjka van den Tol; Sybren Meijer; Cornelis van Kuijk
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

Review 9.  Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Authors:  Domenico Albano; Federico Bruno; Andrea Agostini; Salvatore Alessio Angileri; Massimo Benenati; Giulia Bicchierai; Michaela Cellina; Vito Chianca; Diletta Cozzi; Ginevra Danti; Federica De Muzio; Letizia Di Meglio; Francesco Gentili; Giuliana Giacobbe; Giulia Grazzini; Irene Grazzini; Pasquale Guerriero; Carmelo Messina; Giuseppe Micci; Pierpaolo Palumbo; Maria Paola Rocco; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2021-12-24       Impact factor: 2.374

Review 10.  Colorectal cancer: imaging surveillance following resection of primary tumour.

Authors:  Ken Miles; Guy Burkill
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.